MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CATX made $209,000 in revenue. -$25,969,000 in net income. Net profit margin of -12425.36%.

Income Overview

Revenue
$209,000
Net Income
-$25,969,000
Net Profit Margin
-12425.36%
EPS
-$0.35
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Grant revenue
209,000 290,000 342,000 361,666.667
Research and development
20,339,000 16,620,000 14,332,000 9,870,000
Goodwill, impairment loss
---6,015,500
General and administrative
7,731,000 7,709,000 7,842,000 6,546,000
Loss on disposal of property and equipment
---2,000,666.667
Total operating expenses
28,070,000 24,329,000 22,174,000 24,445,666.667
Operating loss
-27,861,000 -24,039,000 -21,832,000 -24,084,000
Interest income
1,957,000 2,159,000 2,384,000 2,311,333.333
Interest and other expense
65,000 119,000 128,000 -
Other income from a related party (note 3)
0 0 1,400,000 -
Equity in loss of affiliate
0 0 -1,000 -2,000
Interest and other expense, net
---12,000
Total non-operating income, net
1,892,000 2,040,000 3,655,000 2,315,666.667
Net loss from continuing operations
-25,969,000 -21,999,000 -18,177,000 -21,768,333.333
Net loss before deferred income tax benefit
----22,084,666.667
Deferred income tax benefit
----524,250
Net gain (loss) from discontinued operations
0 514,000 --237,250
Net loss
-25,969,000 -21,485,000 -18,177,000 -21,385,666.667
Basic and diluted (in shares)
74,296,000 74,235,000 72,357,000 -2,068,000
Basic loss per share
-0.35 -0.29 -0.25 -0.34
Diluted loss per share
-0.35 -0.29 -0.25 -0.34
Weighted average number of shares outstanding, diluted, total
74,296,000 74,235,000 72,357,000 -2,068,000
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$25,969,000 Interest income$1,957,000 Net loss fromcontinuing operations-$25,969,000 Total non-operatingincome, net$1,892,000 Interest and otherexpense$65,000 Operating loss-$27,861,000 Grant revenue$209,000 Total operatingexpenses$28,070,000 General andadministrative$7,731,000 Research and development$20,339,000

Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc. (CATX)